MINJUVI 200 mg powder for concentrate for solution for infusion
INCA000585-201
Phase 3 small_molecule active
Quick answer
MINJUVI 200 mg powder for concentrate for solution for infusion for Immune-mediated thrombocytopenia, Autoimmune thrombocytopenia, Autoimmune hemolytic anemia is a Phase 3 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Immune-mediated thrombocytopenia, Autoimmune thrombocytopenia, Autoimmune hemolytic anemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active